XORTX Therapeutics Inc
NASDAQ:XRTX
Cash Flow Statement
Cash Flow Statement
XORTX Therapeutics Inc
| Nov-2013 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||||
| Net Income |
(21)
|
(0)
|
(1)
|
(1)
|
(3)
|
(3)
|
(11)
|
(1)
|
(3)
|
(4)
|
4
|
(7)
|
(5)
|
(6)
|
(7)
|
(2)
|
(3)
|
(1)
|
(1)
|
(3)
|
(1)
|
(2)
|
(2)
|
|
| Depreciation & Amortization |
18
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Deffered Taxes |
16
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
3
|
0
|
0
|
0
|
2
|
1
|
9
|
(2)
|
(5)
|
(6)
|
(14)
|
(2)
|
(3)
|
(2)
|
(1)
|
(4)
|
(2)
|
(3)
|
(3)
|
(1)
|
(3)
|
(1)
|
(1)
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
50
|
(2)
|
(2)
|
0
|
(0)
|
2
|
2
|
(1)
|
(0)
|
0
|
1
|
1
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
0
|
(0)
|
0
|
1
|
0
|
0
|
|
| Cash from Operating Activities |
67
N/A
|
(2)
N/A
|
(2)
-5%
|
(1)
+76%
|
(2)
-249%
|
(1)
+69%
|
(1)
+7%
|
(4)
-690%
|
(8)
-90%
|
(10)
-19%
|
(9)
+6%
|
(8)
+9%
|
(8)
+0%
|
(7)
+8%
|
(9)
-21%
|
(7)
+27%
|
(5)
+18%
|
(4)
+18%
|
(4)
+7%
|
(4)
+10%
|
(3)
+18%
|
(3)
-2%
|
(3)
+4%
|
|
| Investing Cash Flow | ||||||||||||||||||||||||
| Capital Expenditures |
(19)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Cash from Investing Activities |
(19)
N/A
|
(0)
+100%
|
(0)
-67%
|
(0)
+7%
|
(0)
-36%
|
(0)
-24%
|
(0)
-42%
|
(0)
-9%
|
(0)
-54%
|
(0)
-40%
|
(0)
+25%
|
(0)
-1%
|
(0)
-33%
|
(0)
+30%
|
(0)
-24%
|
(0)
+12%
|
(0)
+37%
|
(0)
+2%
|
(0)
-55%
|
(0)
+13%
|
(0)
-2%
|
(0)
-32%
|
(0)
+34%
|
|
| Financing Cash Flow | ||||||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
2
|
2
|
1
|
8
|
6
|
6
|
18
|
18
|
18
|
18
|
5
|
5
|
5
|
5
|
0
|
2
|
2
|
2
|
4
|
2
|
2
|
3
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Cash Paid for Dividends |
(62)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(1)
|
|
| Cash from Financing Activities |
(62)
N/A
|
2
N/A
|
2
N/A
|
1
-74%
|
8
+1 136%
|
5
-31%
|
5
-1%
|
17
+219%
|
17
+2%
|
17
+0%
|
17
-2%
|
4
-77%
|
5
+21%
|
5
0%
|
5
+10%
|
(0)
N/A
|
1
N/A
|
1
0%
|
1
0%
|
3
+104%
|
1
-59%
|
1
-3%
|
2
+72%
|
|
| Change in Cash | ||||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
(0)
|
1
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
(0)
|
|
| Net Change in Cash |
(14)
N/A
|
0
N/A
|
0
-49%
|
0
-36%
|
6
+7 017%
|
5
-19%
|
5
-1%
|
13
+172%
|
9
-28%
|
8
-13%
|
9
+8%
|
(4)
N/A
|
(3)
+40%
|
(2)
+13%
|
(4)
-67%
|
(7)
-79%
|
(4)
+42%
|
(3)
+24%
|
(3)
+10%
|
(1)
+65%
|
(2)
-99%
|
(2)
-4%
|
(1)
+45%
|
|
| Free Cash Flow | ||||||||||||||||||||||||
| Free Cash Flow |
48
N/A
|
(2)
N/A
|
(2)
-6%
|
(1)
+76%
|
(2)
-245%
|
(1)
+69%
|
(1)
+6%
|
(4)
-659%
|
(8)
-90%
|
(10)
-19%
|
(9)
+6%
|
(8)
+9%
|
(8)
N/A
|
(8)
+8%
|
(9)
-21%
|
(7)
+27%
|
(5)
+18%
|
(4)
+18%
|
(4)
+7%
|
(4)
+10%
|
(3)
+18%
|
(3)
-2%
|
(3)
+4%
|
|